Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Two companies focused on producing infant formulas have signed license agreements for the use of Martek Biosciences manufactured versions of fatty acids found in breast milk.
Subscribe to our email newsletter
Sweden’s Semper AB has licensed the acids, known as DHA and ARA, for use in infant formulas in territories including Finland, Sweden, Latvia and Lithuania, whilst Korea’s Pasteur Milk Co has acquired the license for South Korea.
Martek manufactures nutritional oils that contain the long-chain polyunsaturated fatty acids, DHA and ARA, both of which are naturally present in breast milk. Clinical studies have demonstrated benefits for those infants receiving DHA and ARA supplemented formula. Martek’s proprietary blend of DHA and ARA is the only source of these nutrients that the FDA has cleared for use in US infant formula, and is currently being sold by the company’s licensees in supplemented formulas in over 60 countries around the world.
“Formula companies worldwide continue to recognize the value of adding Martek’s DHA and ARA to infant formula,” said Henry Linsert Jr, chairman and CEO of Martek Biosciences Corporation. “These two agreements should soon lead to infant formulas containing Martek’s oils in new areas of the world.”